Skin and Soft Tissue Abscess in Adults

Overview

A skin abscess is a localized collection of purulent material (pus) within the dermis and subcutaneous tissue, presenting as a fluctuant, tender, erythematous swelling. Cutaneous abscesses represent one of the most common presentations to emergency departments, accounting for approximately 2-3% of all ED visits in the United States. [1] The incidence has risen substantially over the past two decades, primarily driven by the emergence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). [2]

Incision and drainage (I&D) remains the definitive treatment for skin abscesses and is typically sufficient for uncomplicated cases. [3] The role of adjunctive antibiotics has been clarified by high-quality randomized controlled trials, demonstrating modest benefit in selected populations but not universal necessity. [4] Understanding the distinction between simple cutaneous abscess and more serious deep soft tissue infections, particularly necrotizing fasciitis, is critical for emergency physicians.

The clinical approach to skin abscesses involves accurate diagnosis (often aided by point-of-care ultrasound), appropriate procedural intervention, judicious antibiotic use, and careful patient selection for outpatient versus inpatient management. This topic provides an evidence-based framework for the comprehensive management of adult patients presenting with skin and soft tissue abscesses.

---

Epidemiology

Incidence and Prevalence

Skin and soft tissue infections (SSTIs), including abscesses, are among the most frequent bacterial infections encountered in clinical practice. Emergency department visits for skin abscesses increased from 1.2 million in 1993 to 3.4 million in 2005, representing a nearly 3-fold increase over 12 years. [1] This dramatic rise correlates temporally with the emergence and dissemination of CA-MRSA strains, particularly the USA300 clone. [2]

Demographics

• Age: Abscesses can occur at any age, with peak incidence in young to middle-aged adults (20-50 years). [1]
• Sex: Slight male predominance (approximately 1.3:1 male-to-female ratio). [1]
• Anatomic sites: Most commonly affects areas prone to friction, moisture, and hair follicles including buttocks (30%), trunk (20%), extremities (25%), groin/perineum (15%), and axillae (10%). [5]

Risk Factors

Notably, the majority of patients presenting with simple skin abscesses have no identifiable underlying immunocompromise, highlighting the pathogenic virulence of CA-MRSA strains. [2,6]

---

Aetiology and Pathophysiology

Microbiology

Staphylococcus aureus is the predominant pathogen in cutaneous abscesses, isolated in 75-80% of cultured specimens. [3,4] The emergence of CA-MRSA has fundamentally altered the epidemiology of skin abscesses. CA-MRSA strains, particularly USA300, possess enhanced virulence factors including Panton-Valentine leukocidin (PVL), phenol-soluble modulins, and other toxins that promote tissue destruction and abscess formation. [2]

Exam Detail: CA-MRSA Virulence Mechanisms:

CA-MRSA strains differ from healthcare-associated MRSA (HA-MRSA) in several key ways:

1. SCCmec Type IV or V: Smaller mobile genetic element conferring methicillin resistance, associated with faster growth and greater fitness
2. Panton-Valentine Leukocidin (PVL): Cytotoxin that destroys leukocytes and creates tissue necrosis, strongly associated with abscess formation
3. Phenol-Soluble Modulins (PSMs): Promote neutrophil lysis and contribute to immune evasion
4. Arginine Catabolic Mobile Element (ACME): Enhances bacterial survival in acidic environments and skin colonization
5. Alpha-toxin: Causes membrane pore formation and cellular destruction

These virulence factors explain why CA-MRSA causes predominantly purulent infections (abscesses) rather than diffuse cellulitis.

Pathogenesis

Abscess formation follows a predictable sequence:

1. Bacterial inoculation: Organisms enter through breached skin barrier (hair follicle, minor trauma, insect bite, injection site)
2. Local colonization and proliferation: Bacteria multiply in dermis and subcutaneous tissue
3. Inflammatory response: Neutrophil recruitment, release of cytokines (IL-1β, TNF-α, IL-6), and chemokines
4. Tissue destruction: Bacterial toxins and neutrophil enzymes cause localized necrosis
5. Abscess cavity formation: Central liquefactive necrosis creates pus (dead neutrophils, bacteria, tissue debris)
6. Fibrin wall formation: Host response creates fibrous capsule around abscess cavity
7. Fluctuance: Liquid purulent material creates palpable fluid wave

The fibrin capsule that forms around an abscess creates a barrier that limits antibiotic penetration, explaining why surgical drainage is essential and antibiotics alone are inadequate for treatment. [3]

Anatomic Variants

• Furuncle (boil): Infection of a single hair follicle extending into subcutaneous tissue
• Carbuncle: Coalescence of multiple furuncles with multiple drainage points; more extensive and typically requires antibiotics
• Pilonidal abscess: Occurs in natal cleft, often contains hair; high recurrence rate without definitive surgical management
• Hidradenitis suppurativa: Chronic inflammatory condition of apocrine glands with recurrent abscesses in axillae, groin, and inframammary regions
• Perianal/perirectal abscess: Involves anal cryptoglandular tissue; may indicate underlying fistula-in-ano

---

Clinical Presentation

Symptoms

Patients typically present with localized symptoms at the site of infection:

Systemic symptoms (less common in simple abscess):

• Fever: Present in less than 20% of uncomplicated abscesses
• Malaise, fatigue: Suggests more extensive infection
• Rigors: Concerning for bacteremia

The presence of systemic symptoms should prompt consideration of:

• Extensive surrounding cellulitis (> 2-5 cm erythema beyond abscess)
• Bacteremia or systemic infection
• Deep space infection
• Necrotizing soft tissue infection

Physical Examination

A systematic approach to examination includes:

Inspection:

• Size of abscess (measure and document in cm)
• Presence of fluctuance (compressible, fluid-filled sensation)
• Surrounding erythema (measure extent from abscess edge)
• Skin changes (bullae, crepitus, ecchymosis suggest necrotizing infection)
• Spontaneous drainage or pointing (thin overlying skin)
• Number of abscesses (multiple lesions may indicate CA-MRSA with auto-inoculation)

Palpation:

• Fluctuance: Key finding distinguishing abscess from cellulitis
• Tenderness
• Induration (firmness of surrounding tissue)
• Depth (superficial vs. deep)
• Regional lymphadenopathy

Systemic assessment:

• Vital signs (fever, tachycardia, hypotension)
• Signs of systemic toxicity

Clinical Pearl: Fluctuance Assessment Technique:

Use two-finger palpation technique: Apply gentle pressure with index fingers positioned opposite each other across the swelling. A positive fluid wave (movement of fluid between fingers) confirms fluctuance. Early abscesses may be indurated without clear fluctuance; if clinical suspicion is high, point-of-care ultrasound can confirm the presence of a drainable fluid collection.

Special Presentations

Injection drug users:

• Often have abscesses at injection sites (antecubital fossae, forearms, groin, neck)
• Higher risk of polymicrobial infections including anaerobes and Gram-negatives
• Must assess for complications: septic thrombophlebitis, endocarditis (especially if fever), osteomyelitis, septic arthritis
• Consider blood cultures if febrile

Diabetic patients:

• May have attenuated inflammatory response despite significant infection
• Higher risk of treatment failure and complications
• Lower threshold for antibiotics and close follow-up

Immunocompromised patients:

• Broader differential (atypical mycobacteria, fungi, nocardia)
• More aggressive management typically warranted
• Consider unusual organisms and extended cultures

---

Red Flags and Dangerous Diagnoses

Necrotizing Soft Tissue Infections

Necrotizing fasciitis is a surgical emergency with mortality rates of 20-40% despite treatment. [8] Early recognition is crucial but challenging, as initial presentation may mimic simple cellulitis or abscess.

Warning Signs:

LRINEC Score (Laboratory Risk Indicator for Necrotizing Fasciitis):

The LRINEC score helps risk-stratify patients for necrotizing fasciitis. [9] However, it should not replace clinical judgment, and suspicion should remain high even with low scores.

Score interpretation:

• ≥8: High risk for necrotizing fasciitis (PPV 57%, NPV 96%)
• 6-7: Intermediate risk
• less than 6: Low risk (but does not exclude diagnosis)

Management of suspected necrotizing fasciitis:

1. Immediate surgical consultation (do not delay for imaging)
2. Resuscitation: IV fluids, vasopressors if needed
3. Broad-spectrum IV antibiotics: Cover Gram-positives, Gram-negatives, and anaerobes (e.g., vancomycin + piperacillin-tazobactam + clindamycin)
4. Imaging: CT with IV contrast may show fascial gas, fluid tracking along fascial planes, but should not delay surgery
5. Emergent surgical debridement: Definitive diagnosis and treatment

Other Serious Complications

---

Differential Diagnosis

Exam Detail: Cellulitis vs. Abscess - Key Distinction:

This is one of the most important clinical discriminations in emergency medicine:

Cellulitis:

• Diffuse spreading erythema
• Induration without discrete mass
• No fluctuance
• Treatment: Antibiotics (typically β-lactam for streptococcal coverage)

Abscess:

• Localized, well-defined swelling
• Fluctuant (fluid wave)
• Central collection of pus
• Treatment: Incision and drainage (antibiotics often unnecessary)

Abscess with surrounding cellulitis:

• Fluctuant central mass with erythema extending > 2-5 cm beyond abscess
• Treatment: I&D + antibiotics

Ultrasound has become invaluable in making this distinction when clinical examination is equivocal, with sensitivity of 90-98% for detecting fluid collections. [10]

---

Investigations

Clinical Diagnosis

Most skin abscesses are diagnosed clinically based on history and physical examination. The presence of fluctuance is the hallmark finding. Laboratory testing and imaging are not routinely required for uncomplicated abscesses in immunocompetent patients without systemic symptoms.

Point-of-Care Ultrasound

Ultrasound has emerged as a highly valuable adjunct in evaluating suspected abscesses. [10]

Indications for ultrasound:

• Uncertain diagnosis (abscess vs. cellulitis)
• Location of abscess for I&D guidance
• Assessment of abscess depth and size
• Detection of loculations
• Evaluation for foreign body
• Difficult anatomic locations (e.g., peritonsillar, breast, deep gluteal)

Ultrasound findings of abscess:

• Hypoechoic or anechoic fluid collection (dark/black area)
• Posterior acoustic enhancement (increased brightness deep to fluid)
• Swirling debris when compressed (mobile particulate matter)
• Hyperechoic rim (surrounding inflammatory tissue)
• Cobblestoning (loculations/septations)

Sensitivity and specificity: Ultrasound has sensitivity of 90-98% and specificity of 70-88% for detecting drainable fluid collections. [10]

Microbiological Studies

Wound culture and sensitivity:

Routine wound cultures are not necessary for all abscesses. [3,11]

Indications for wound culture:

• Large abscess (> 5 cm)
• Recurrent abscess
• Concern for MRSA
• Failed initial treatment
• Immunocompromised patient
• Systemic symptoms/signs of severe infection
• Unusual location (face, hands, genitals)
• Suspected atypical organism

Collection technique:

• Obtain pus from abscess cavity (not superficial swab)
• Send for Gram stain and culture with sensitivities
• Consider anaerobic culture for perianal/perirectal abscesses

Blood Tests

Not routinely indicated for simple abscess, but consider in specific situations:

Imaging Studies

Computed Tomography (CT):

Not routinely needed for simple abscesses. Consider for:

• Suspected deep space abscess (e.g., psoas, intra-abdominal, pelvic)
• Concern for necrotizing fasciitis (shows fascial gas, fluid tracking along fascial planes, lack of fascial enhancement)
• Perirectal abscess to define anatomy and exclude fistula
• Failed drainage to assess for undrained collection

Magnetic Resonance Imaging (MRI):

Rarely indicated acutely. May be useful for:

• Osteomyelitis evaluation
• Spinal epidural abscess
• Complex perianal fistulizing disease

---

Classification and Staging

IDSA Classification of SSTIs

The Infectious Diseases Society of America (IDSA) classifies SSTIs to guide management: [3]

Abscess Severity Classification

While no formal severity grading exists, clinical classification guides management:

---

Management

Principles of Management

The cornerstone of abscess management is source control through incision and drainage. [3,4] Antibiotics do not adequately penetrate the fibrous capsule and necrotic debris of an abscess cavity and are therefore insufficient as monotherapy.

Treatment approach algorithm:

1. All abscesses: Incision and drainage
2. Select cases: Adjunctive antibiotics (see indications below)
3. Analgesia: Appropriate pain control
4. Wound care: Dressing and follow-up instructions
5. Disposition: Outpatient vs. admission decision

Incision and Drainage Technique

Preparation:

1. Informed consent (explain procedure, pain, recurrence risk, scarring)
2. Position patient comfortably with good lighting
3. Gather equipment: scalpel (#11 blade typically), forceps, irrigation, packing material, dressing
4. Consider ultrasound guidance for deep or uncertain abscesses

Anesthesia:

Clinical Pearl: Buffered lidocaine reduces injection pain: Adding sodium bicarbonate (1 mL of 8.4% NaHCO₃ to 9 mL of 1% lidocaine) neutralizes the acidic pH and significantly reduces injection discomfort.

For very painful abscesses, consider procedural sedation (e.g., ketamine, propofol) rather than attempting inadequate local anesthesia.

I&D Procedure:

1. Prepare the skin: Chlorhexidine or povidone-iodine cleansing
2. Anesthetize: Field block or local infiltration around (not into) abscess
3. Incision:
   • Make incision over point of maximum fluctuance
   • Incision length should be adequate to allow complete drainage (typically 1-2 cm minimum)
   • Linear incision along lines of skin tension when possible
   • Avoid crossing joints or important structures
4. Express pus: Apply gentle pressure to evacuate purulent material completely
5. Break up loculations: Use hemostat or gloved finger to gently explore cavity and break adhesions
6. Irrigate: Copious irrigation with normal saline (100-500 mL depending on size)
7. Culture: If indicated, collect pus specimen for culture
8. Pack (controversial - see below): Consider packing for large cavities
9. Dress: Apply absorbent dressing

Loop Drainage Technique:

An alternative to traditional I&D is loop drainage (also called "punch and loop" or "modified I&D"), which has gained popularity in emergency medicine. [11]

Technique:

1. Make 2 small stab incisions (using #11 blade or dermal punch) at opposite ends of abscess
2. Thread vessel loop or Penrose drain through abscess cavity
3. Tie loop loosely to allow drainage
4. Remove after 5-7 days

Advantages of loop drainage:

• Less painful than traditional I&D
• No packing required
• Smaller scars
• Patient can perform dressing changes at home
• Similar cure rates to traditional I&D

Evidence: A systematic review found loop drainage to be non-inferior to traditional I&D with potential advantages in pain and patient satisfaction. [11]

The Packing Debate

Wound packing after I&D has been traditional practice, but recent evidence has challenged this dogma.

Historical rationale for packing:

• Prevents premature skin closure
• Allows continued drainage
• Maintains cavity patency
• Tamponades bleeding

Evidence against routine packing:

Multiple randomized controlled trials have now demonstrated that packing may not be necessary for most simple abscesses:

1. Perianal abscesses (PPAC2 trial, 2022): 433 patients randomized to packing vs. non-packing showed non-packing resulted in significantly less pain (VAS 28.2 vs. 38.2, pless than 0.0001) with no difference in fistula formation or recurrence. [12]

2. General cutaneous abscesses: Studies have shown no difference in cure rates or recurrence with or without packing for abscesses less than 5 cm. [13]

Current recommendations:

If packing is placed:

• Use iodoform or plain gauze ribbon (not cotton balls or tightly-packed material)
• Pack loosely to allow drainage, not tightly
• Remove/repack at 24-48 hours
• Discontinue packing once drainage minimal

Antibiotics: Evidence-Based Indications

The role of adjunctive antibiotics after adequate I&D has been definitively studied in high-quality randomized controlled trials.

Landmark Trial - Talan et al., NEJM 2016: [4]

1,247 patients with uncomplicated skin abscesses randomized to trimethoprim-sulfamethoxazole vs. placebo after I&D:

• Primary outcome (cure): 80.5% in TMP-SMX group vs. 73.6% in placebo (difference 6.9%, p=0.005)
• Secondary infections: 4.4% vs. 8.6% in placebo group
• Conclusion: TMP-SMX provides modest benefit but most patients cured with drainage alone

Current Evidence-Based Indications for Antibiotics:

Antibiotics NOT routinely indicated:

• Simple, uncomplicated abscess less than 5 cm
• Minimal surrounding erythema (less than 2 cm)
• Immunocompetent patient
• No systemic symptoms
• Adequate drainage achieved

Evidence Debate: The Antibiotic Question: Clinical Nuance

The Talan trial showed statistical benefit of TMP-SMX (6.9% absolute improvement in cure rate), but the clinical significance is debated:

Arguments FOR routine antibiotics:

• Statistically significant benefit demonstrated
• Reduces new lesions and household transmission
• Modest cost, generally well-tolerated
• High MRSA prevalence

Arguments AGAINST routine antibiotics:

• Number needed to treat = 14 (to prevent one treatment failure)
• 73.6% cured with drainage alone
• Antibiotic stewardship concerns
• Adverse effects (C. difficile risk, allergic reactions, drug interactions)
• Cost and patient burden

Current consensus: Shared decision-making, considering individual patient factors and local MRSA prevalence. Most guidelines support antibiotics for complicated or high-risk cases but not universally for simple abscesses. [3,5]

Antibiotic Regimens

When antibiotics are indicated, they must provide MRSA coverage for purulent SSTIs. [3]

Oral Regimens (Outpatient):

For suspected streptococcal involvement (non-purulent cellulitis component):

• Add β-lactam: Cephalexin 500 mg QID, amoxicillin-clavulanate 875/125 mg BID
• OR use clindamycin monotherapy (covers both MRSA and strep, but C. diff risk)

Intravenous Regimens (Inpatient):

Special Situations:

• Pregnant/breastfeeding: Cephalexin (for strep), clindamycin (for MRSA); avoid doxycycline and TMP-SMX (especially 1st and 3rd trimesters)
• Penicillin allergy: Doxycycline or clindamycin
• Renal impairment: Adjust doses, avoid TMP-SMX if severe
• Perianal/perirectal abscess: Add anaerobic coverage (metronidazole or amoxicillin-clavulanate)

Analgesia

Abscesses and I&D procedures are painful. Adequate analgesia is essential for patient comfort and procedural success.

Post-procedure pain: Often significant in first 24-48 hours. Provide adequate analgesia instructions and prescription.

Wound Care

Dressing:

• Absorbent gauze dressing to collect drainage
• Change daily or when saturated
• Keep clean and dry

Irrigation:

• May irrigate with saline or soapy water in shower after 24 hours
• Pat dry, apply clean dressing

Activity:

• No specific restrictions unless abscess location impairs function
• Avoid hot tubs, swimming pools until healed

Follow-up:

• If packed: Return in 24-48 hours for packing removal/change
• Unpacked wounds: Follow up with primary care in 1-2 weeks if not improving
• Return immediately for warning signs (see below)

---

Disposition

Outpatient Management (Majority)

Criteria for safe discharge:

• Successful I&D performed
• Small to moderate abscess size
• Minimal surrounding cellulitis
• No systemic symptoms
• Immunocompetent
• Able to perform wound care or have follow-up arranged
• Reliable patient with access to care
• No high-risk location (e.g., extensive facial abscess)

Discharge instructions:

• Wound care education (verbal and written)
• Analgesics
• Antibiotics (if indicated)
• Follow-up plan
• Return precautions (warning signs)

Return precautions (instruct patient to return immediately for):

• Fever or chills
• Worsening or spreading redness
• Increasing pain despite pain medication
• Red streaks extending from wound
• Purulent drainage increasing
• No improvement after 48 hours
• Numbness around wound
• Difficulty moving nearby joints

Hospital Admission

Indications for admission:

Specialist Referral

---

Recurrent Abscesses and MRSA Decolonization

Epidemiology of Recurrence

Approximately 15-30% of patients who present with a skin abscess will develop at least one recurrent episode within 12 months. [7] Recurrence is associated with:

• MRSA colonization (nasal, axillary, groin)
• Household contacts with MRSA
• Crowded living conditions
• Contact sports participation
• Injection drug use
• Underlying dermatologic conditions (hidradenitis suppurativa)

Decolonization Strategies

Indications for decolonization:

• Recurrent MRSA skin infections (≥2 episodes in 6-12 months)
• Household contacts with recurrent MRSA infections
• Outbreaks in closed settings (sports teams, military units)

Evidence for decolonization:

The benefit of MRSA decolonization for preventing recurrent skin infections is controversial. Some studies show benefit, while others (including a large pediatric study) showed decolonization protocols did not reduce recurrence. [14] However, decolonization is reasonable to attempt in patients with truly recurrent infections.

Decolonization Regimen:

Clinical Pearl: Bleach Bath Instructions for Patients:

Add ¼ to ½ cup (60-120 mL) of regular household bleach (6% sodium hypochlorite) to a full bathtub of water (approximately 40 gallons/150 L). This creates a dilute solution similar to swimming pool chlorination. Soak for 10-15 minutes, twice weekly. Pat dry (do not rinse off). This is safe and generally well-tolerated, though patients with sensitive skin or eczema may experience irritation.

Additional measures for recurrent infections:

• Avoid sharing towels, razors, clothing
• Shower immediately after exercise or contact sports
• Keep cuts and abrasions clean and covered
• Hand hygiene education
• Launder clothes and linens in hot water
• Consider intranasal mupirocin prophylaxis during high-risk periods (e.g., wrestling season)

Hidradenitis Suppurativa

Recurrent abscesses in axillae, groin, or inframammary regions may represent hidradenitis suppurativa (HS), a chronic inflammatory condition of apocrine glands. [15]

Diagnostic features:

• Recurrent painful nodules and abscesses in apocrine gland-bearing areas
• Double-ended comedones (pathognomonic)
• Sinus tract formation
• Hypertrophic scarring
• Onset typically in 2nd-3rd decade

Management:

• Acute flares: I&D, antibiotics (doxycycline, clindamycin)
• Chronic disease: Dermatology referral
  • Topical clindamycin
  • Oral antibiotics (long-term tetracyclines, clindamycin-rifampin combination)
  • Biologics (adalimumab, recently approved secukinumab and bimekizumab) [15]
  • Intralesional corticosteroids
  • Definitive surgical excision for refractory disease
• Lifestyle: Weight loss, smoking cessation, avoid tight clothing

---

Special Populations

Diabetic Patients

Diabetes is associated with:

• Impaired neutrophil function and chemotaxis
• Microvascular disease impairing tissue perfusion
• Neuropathy masking symptoms
• Higher rates of MRSA colonization

Management considerations:

• Lower threshold for antibiotics
• Close follow-up (48-72 hours)
• Assess glycemic control
• Careful foot examination if lower extremity abscess
• Higher index of suspicion for deeper infection (osteomyelitis, septic arthritis)

Immunocompromised Patients

Causes of immunocompromise:

• HIV/AIDS (especially CD4 less than 200)
• Chemotherapy
• Chronic corticosteroids
• Biologics (anti-TNF agents, others)
• Organ transplantation (immunosuppressive medications)
• Hematologic malignancies
• Functional asplenia

Management modifications:

• Broader differential diagnosis (atypical mycobacteria, fungi, nocardia)
• Extended cultures (AFB, fungal)
• Lower threshold for antibiotics and admission
• Consider broader-spectrum antibiotics
• Closer follow-up
• Infectious disease consultation for complex cases

Injection Drug Users (IVDU)

Unique considerations:

• Abscesses often at injection sites
• Higher risk of polymicrobial infection (MRSA + Gram-negatives + anaerobes)
• Complications: bacteremia, endocarditis (20% of IVDU with S. aureus bacteremia), septic thrombophlebitis, osteomyelitis, epidural abscess
• Contaminants: Clostridium (from black tar heroin), Candida, Eikenella

Management approach:

• Blood cultures if febrile (before antibiotics)
• Consider echocardiography if bacteremic or new murmur
• Broader antibiotic coverage if severe: Vancomycin + piperacillin-tazobactam
• Social work involvement: Substance use disorder treatment referral, harm reduction (needle exchange)
• Screen for HIV, hepatitis B and C

Pregnancy

Skin abscesses in pregnancy are managed similarly to non-pregnant patients with modifications:

Antibiotic considerations:

• Safe: β-lactams (penicillins, cephalosporins), clindamycin
• Avoid: Doxycycline (teratogenic), TMP-SMX (especially 1st trimester and near delivery - kernicterus risk)
• For MRSA: Clindamycin is preferred agent

Procedural considerations:

• I&D can be performed safely
• Local anesthesia (lidocaine) is safe
• Position patient comfortably (left lateral tilt in late pregnancy)

---

Complications

---

Prognosis

Uncomplicated Abscess

With appropriate drainage, the prognosis for simple skin abscess is excellent:

• Cure rate: 70-90% with drainage alone [4]
• Healing time: Most heal within 7-14 days
• Return to normal activity: Usually within days
• Recurrence: 15-30% will have at least one recurrence [7]

Complicated SSTI

• Bacteremia: 5-10% incidence in severe SSTIs; requires 2-4 weeks IV antibiotics
• Endocarditis: 20% of IVDU with S. aureus bacteremia have endocarditis; mortality 20-40%
• Necrotizing fasciitis: Mortality 20-40% despite treatment [8]

Factors Associated with Treatment Failure

---

Prevention and Public Health

Primary Prevention

Individual level:

• Hand hygiene (handwashing with soap and water or alcohol-based sanitizer)
• Keep cuts and abrasions clean and covered with bandages until healed
• Avoid sharing personal items (towels, razors, clothing)
• Shower immediately after exercise or contact sports
• Maintain good general hygiene

Community level:

• Environmental cleaning (disinfection of shared equipment in gyms, athletic facilities)
• Education programs in high-risk settings (schools, correctional facilities, military)
• Athletic trainers screening for skin infections
• Exclusion policies for contact sports when active infections present

Secondary Prevention (Preventing Recurrence)

• MRSA decolonization protocols for recurrent infections
• Household contact screening and decolonization
• Treatment of underlying conditions (diabetes control, hidradenitis suppurativa management)
• Avoidance of triggers (shaving in affected areas, occlusive clothing)

Public Health Surveillance

CA-MRSA is not a reportable disease in most jurisdictions, but outbreaks should be reported to local health departments for:

• Contact investigation
• Infection control guidance
• Environmental assessment
• Decolonization recommendations

---

Quality Metrics and Documentation

Performance Indicators

Essential Documentation

Comprehensive documentation should include:

History:

• Duration of symptoms
• Prior similar infections (recurrence)
• MRSA history (self or household contacts)
• Risk factors (diabetes, immunosuppression, IVDU)
• Antibiotic allergies

Physical Examination:

• Abscess location (specific anatomic description)
• Size (measure in cm: length × width × depth or diameter)
• Presence of fluctuance
• Extent of surrounding erythema (measure from abscess edge)
• Presence of multiple abscesses
• Lymphadenopathy
• Vital signs (document if normal)

Procedure:

• Informed consent obtained
• Anesthesia method and agents used
• Incision length and technique
• Volume/character of purulent drainage
• Breaking of loculations
• Irrigation volume
• Packing (yes/no; if yes, type and amount)
• Culture sent (yes/no)
• Patient tolerance

Treatment:

• Antibiotics prescribed (yes/no; if yes, drug, dose, duration, indication)
• Analgesia provided
• Wound care instructions given (verbal and written)

Disposition:

• Discharge vs. admission with rationale
• Follow-up plan (timing, location, for what purpose)
• Return precautions given (document specific warning signs discussed)
• Patient understanding confirmed

---

Key Clinical Pearls

Diagnostic Pearls

1. Fluctuance is the key finding: If you can elicit a fluid wave, there is a drainable collection
2. "When in doubt, ultrasound": Point-of-care ultrasound rapidly differentiates abscess from cellulitis with 90-98% sensitivity [10]
3. Pain out of proportion = necrotizing fasciitis until proven otherwise: Don't miss this deadly diagnosis
4. Perianal abscess requires surgical evaluation: High rate of underlying fistula-in-ano; needs proper surgical drainage
5. Recurrent abscesses in axilla/groin = think hidradenitis suppurativa: Look for double-comedones and scarring; requires different management
6. IVDU with fever and abscess = get blood cultures: 20% with bacteremia have endocarditis

Treatment Pearls

1. I&D is the definitive treatment; antibiotics are adjunctive: Never treat abscess with antibiotics alone
2. Adequate drainage is more important than antibiotics: Ensure complete evacuation and break up loculations
3. Packing is probably unnecessary for most abscesses: Recent evidence favors no packing for less pain without increased recurrence [12,13]
4. Loop drainage is a valid alternative to traditional I&D: Less painful, no packing needed, similar outcomes [11]
5. TMP-SMX after drainage provides modest benefit (NNT=14): Consider patient factors and shared decision-making [4]
6. Cover MRSA empirically if antibiotics are given for purulent SSTI: TMP-SMX, doxycycline, or clindamycin
7. Don't forget analgesia: Abscesses and I&D are very painful; provide adequate pain control

Disposition Pearls

1. Most patients can be safely discharged: Admission is the exception, not the rule
2. Follow-up in 24-48 hours if packed: For packing removal/change
3. Decolonization for recurrent MRSA: Nasal mupirocin + chlorhexidine washes ± bleach baths
4. Admit for "FIST": Fever/sepsis, Immunocompromised, Systemic toxicity, Threat of necrotizing infection

---

Common Exam Questions

Written Exam (MCQ/SBA) Topics

1. What is the most common organism causing skin abscess in the community setting?

   • Answer: Staphylococcus aureus (including MRSA)

2. A 28-year-old presents with a 3 cm fluctuant abscess on the buttock with minimal surrounding erythema. After I&D, what is the most appropriate next step?

   • Answer: Discharge with wound care instructions (no antibiotics needed for simple abscess)

3. Which antibiotic provides the best empiric coverage for community-acquired MRSA skin infection?

   • Answer: TMP-SMX, doxycycline, or clindamycin (know local resistance patterns)

4. What finding most reliably distinguishes necrotizing fasciitis from simple cellulitis/abscess?

   • Answer: Pain out of proportion to physical examination findings

5. What is the evidence-based benefit of routine wound packing after I&D of simple skin abscess?

   • Answer: No benefit; recent RCTs show no packing is less painful without increased recurrence

Viva Voce Topics

Viva Point: Opening statement for skin abscess:

"A skin abscess is a localized collection of purulent material within the dermis and subcutaneous tissue, most commonly caused by Staphylococcus aureus including community-acquired MRSA strains. It presents as a fluctuant, tender, erythematous swelling. The definitive treatment is incision and drainage; antibiotics are adjunctive in select cases such as extensive surrounding cellulitis, immunocompromise, or systemic symptoms."

Key facts to mention:

• Incidence has tripled since emergence of CA-MRSA (3.4 million ED visits annually in US) [1]
• MRSA prevalence in cultured abscesses: 30-75% depending on region [4,6]
• I&D alone cure rate: ~74%; with TMP-SMX: ~81% (NNT=14) [4]
• Packing no longer routinely recommended based on RCT evidence [12,13]
• Recurrence rate: 15-30% within 12 months [7]

Management approach: "My approach would be systematic: First, confirm the diagnosis clinically with fluctuance; use ultrasound if uncertain. Second, perform adequate I&D with complete drainage and breaking of loculations. Third, decide on antibiotics - indicated for surrounding cellulitis, systemic symptoms, immunocompromise, or large abscess; TMP-SMX or doxycycline for MRSA coverage. Fourth, provide analgesia and wound care education. Finally, arrange appropriate follow-up and give clear return precautions, particularly for necrotizing fasciitis warning signs."

OSCE Stations

Common scenarios:

• Perform I&D of skin abscess (procedural station)
• Counsel patient after I&D (communication station)
• Differentiate abscess from necrotizing fasciitis (data interpretation)
• Interpret point-of-care ultrasound images (diagnostic skills)

Common Mistakes

❌ Mistakes that fail candidates:

1. Treating abscess with antibiotics alone without I&D: Source control is essential
2. Missing necrotizing fasciitis: Know the red flags (pain out of proportion, rapid spread, systemic toxicity)
3. Inadequate drainage: Must break up loculations and ensure complete evacuation
4. Wrong antibiotic choice: Purulent SSTI requires MRSA coverage (not cephalexin or amoxicillin alone)
5. Automatically packing all wounds: Know the evidence against routine packing
6. Not sending wound culture when indicated: Large, recurrent, or failed treatment cases need culture
7. Discharging high-risk patient without antibiotics or follow-up: Diabetics, immunocompromised need closer monitoring
8. Ordering unnecessary imaging: CT not needed for simple abscess; clinical diagnosis with ultrasound if needed

---

References

1. Pallin DJ, et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med. 2008;51(3):291-298. doi:10.1016/j.annemergmed.2007.12.004

2. Turner NA, et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol. 2019;17(4):203-218. doi:10.1038/s41579-018-0147-4

3. Stevens DL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10-e52. doi:10.1093/cid/ciu296

4. Talan DA, et al. Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med. 2016;374(9):823-832. doi:10.1056/NEJMoa1507476

5. Long B, Gottlieb M. Diagnosis and management of cellulitis and abscess in the emergency department setting: an evidence-based review. J Emerg Med. 2022;62(1):16-27. doi:10.1016/j.jemermed.2021.09.015

6. Daum RS. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med. 2007;357(4):380-390. doi:10.1056/NEJMcp070747

7. Moran GJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666-674. doi:10.1056/NEJMoa055356

8. Hakkarainen TW, et al. Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg. 2014;51(8):344-362. doi:10.1067/j.cpsurg.2014.06.001

9. Wong CH, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535-1541. doi:10.1097/01.ccm.0000129486.35458.7d

10. Squire BT, et al. The accuracy of emergency department ultrasound in the diagnosis of soft tissue abscesses. J Emerg Med. 2005;29(1):63-67. doi:10.1016/j.jemermed.2005.01.010

11. Gottlieb M, et al. Ultrasound for the diagnosis and management of soft tissue abscesses. West J Emerg Med. 2015;16(5):784-787. doi:10.5811/westjem.2015.7.27453

12. Hardy EJO, et al. Postoperative packing of perianal abscess cavities (PPAC2): randomized clinical trial. Br J Surg. 2022;109(10):951-957. doi:10.1093/bjs/znac225

13. Singer AJ, et al. Comparison of patient and practitioner assessments of pain from commonly performed emergency department procedures. Ann Emerg Med. 1999;33(6):652-658. doi:10.1016/s0196-0644(99)70195-5

14. Fritz SA, et al. Impact of decolonization protocols and recurrence in pediatric MRSA skin and soft-tissue infections. J Surg Res. 2019;242:70-77. doi:10.1016/j.jss.2019.04.040

15. Zouboulis CC, et al. Hidradenitis suppurativa. Lancet. 2025;405(10476):420-438. doi:10.1016/S0140-6736(24)02475-9

16. Bowen AC, et al. Sulfamethoxazole-trimethoprim (cotrimoxazole) for skin and soft tissue infections including impetigo, cellulitis, and abscess. Open Forum Infect Dis. 2017;4(4):ofx232. doi:10.1093/ofid/ofx232

17. Sharara SL, et al. Decolonization of Staphylococcus aureus. Infect Dis Clin North Am. 2021;35(1):107-133. doi:10.1016/j.idc.2020.10.010

18. Miller LG, et al. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med. 2015;372(12):1093-1103. doi:10.1056/NEJMoa1403789

19. Duong M, et al. Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann Emerg Med. 2010;55(5):401-407. doi:10.1016/j.annemergmed.2009.03.014

20. Liu C, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18-e55. doi:10.1093/cid/ciq146

21. May AK, et al. Clinical practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the IDSA. Surg Infect. 2014;15(4):359-365. doi:10.1089/sur.2014.508

22. Abrahamian FM, et al. Antimicrobial therapy for skin and soft tissue infections. Infect Dis Clin North Am. 2021;35(1):81-105. doi:10.1016/j.idc.2020.10.009